Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
Int J Cardiol ; 190: 190-7, 2015.
Article in English | MEDLINE | ID: mdl-25920022

ABSTRACT

BACKGROUND: Diabetes is a major risk factor for acute myocardial infarction (AMI). Assessment of diabetic patients is challenging due to an often atypical presentation of symptoms. We aimed to evaluate the two novel biomarkers copeptin and high-sensitive cardiac troponin (hs-TnT) for the improvement of early diagnosis and risk-stratification in patients with diabetes and suspected AMI. METHODS: In this prospective international multicenter study we evaluated 379 patients with diabetes in a cohort of 1991 patients presenting with symptoms suggestive of AMI. The measurement of biomarkers was performed at presentation. RESULTS: Among the 379 diabetic patients, 32.7% had AMI, and in the 1621 patients without diabetes, 18.8% had AMI. The additional use of copeptin improved the diagnostic accuracy provided by conventional troponin alone (AUC 0.86 vs. 0.79, p=0.004). During a median follow-up of 814 days, 49 (13.1%) diabetic patients died. Cumulative 2-year survival rate for patients with copeptin levels below 9 pmol/l was 96.6% compared to 82.8% in patients above that level (p<0.001). The same was observed for hs-TnT with a cutoff level of 14 ng/l (97.7% vs. 82.0%, p<0.001) respective of cTnT with a cutoff level of 10 ng/l (93.5% vs. 75.6%, p<0.001). In multivariate Cox analysis, copeptin, hs-TnT and cTnT were strong and independent predictors of 24-month-mortality. Using the dual marker strategy (copeptin and troponin) identified two groups of high-risk patients where 22.5% of the group with hs-cTnT and copeptin above the cutoff and 28.6% with cTnT and copeptin above the cutoff died. CONCLUSION: In diabetic patients, copeptin only slightly improves the early diagnosis of AMI provided by hs-cTnT. However, both markers (copeptin and troponin) predict long-term mortality accurately and independently of each other.


Subject(s)
Diabetes Mellitus/blood , Diabetes Mellitus/diagnosis , Glycopeptides/blood , Myocardial Infarction/blood , Myocardial Infarction/diagnosis , Troponin T/blood , Aged , Aged, 80 and over , Biomarkers/blood , Cohort Studies , Diabetes Mellitus/mortality , Early Diagnosis , Female , Follow-Up Studies , Humans , Internationality , Male , Middle Aged , Mortality/trends , Myocardial Infarction/mortality , Prognosis , Prospective Studies
2.
Infection ; 41(2): 431-7, 2013 Apr.
Article in English | MEDLINE | ID: mdl-22987291

ABSTRACT

PURPOSE: Rifampin combination therapy plays an important role in the management of staphylococcal periprosthetic joint infection (PJI). However, the emergence of rifampin resistance is a feared complication. We retrospectively analysed predetermined potential risk factors in patients with rifampin-resistant staphylococcal PJI in a multicentre case-control study. METHODS: Cases (n = 48) were defined as PJI caused by rifampin-resistant staphylococci. Rifampin-susceptible controls (n = 48) were matched for microorganism and type of prosthetic joint. Uni- and multivariable conditional logistic regression analyses were performed to estimate odds ratios (OR) with 95 % confidence intervals (95 % CI). RESULTS: Forty-eight cases (31 men; median age 67 years; age range 39-88 years) with hip- (n = 29), knee- (n = 13), elbow- (n = 4), shoulder- (n = 1) or ankle-PJI (n = 1) were enrolled in the study. Staphylococcus aureus and coagulase-negative staphylococci were isolated in ten and 38 episodes, respectively. Most of the cases (n = 44, 92 %) had a previous PJI, and 93 % (n = 41) of these had been treated with rifampin. There was an independent association of emergence of rifampin resistance with male sex (OR 3.6, 95 % CI 1.2-11), ≥ 3 previous surgical revisions (OR 4.7, 95 % CI 1.6-14.2), PJI treatment with high initial bacterial load (inadequate surgical debridement, <2 weeks of intravenous treatment of the combination medication; OR 4.9, 95 % CI 1.6-15) and inadequate rifampin therapy (OR 5.4, 95 % CI 1.2-25). CONCLUSIONS: Based on our results, extensive surgical debridement and adequate antibiotic therapy are needed to prevent the emergence of rifampin resistance.


Subject(s)
Drug Resistance, Bacterial , Prosthesis-Related Infections/drug therapy , Rifampin/therapeutic use , Staphylococcal Infections/drug therapy , Adult , Aged , Aged, 80 and over , Bacterial Load , Case-Control Studies , Confidence Intervals , Female , Humans , Joint Diseases/surgery , Joint Prosthesis/microbiology , Logistic Models , Male , Middle Aged , Odds Ratio , Prosthesis-Related Infections/microbiology , Retrospective Studies , Risk Factors
3.
J Environ Monit ; 9(11): 1183-93, 2007 Nov.
Article in English | MEDLINE | ID: mdl-17968444

ABSTRACT

An international exercise to directly assess consistency of standards for ground-level ozone in East Asia was conducted as part of the East Asian Regional Experiment 2005 (EAREX 2005) in the framework of the Atmospheric Brown Clouds (ABC) project. Ten organizations collaboratively participated in the intercomparison. Four groups representing Japan, Korea, Hong Kong, and Taiwan made comparisons at the Gosan super observatory, Jeju Island, Korea, in March 2005, with ozone instruments calibrated to their national standards, and four Japanese groups made off-site comparisons with laboratory-level standards. All comparisons generally indicated good agreement with the standard reference photometer (SRP) 35, built by the National Institute of Standards and Technology (USA) and maintained by the National Institute for Environmental Studies (Japan). The assessment was expanded to measurement networks contributing to the World Meteorological Organization's Global Atmospheric Watch (WMO/GAW) program as part of off-site comparisons, and excellent agreement was achieved. These efforts contribute to propagating traceability of the national metrology standards among the atmospheric science community, to ensuring comparability of the existing ozone measurements, and to establishing an integrated network of air quality monitoring in Asia.


Subject(s)
Ozone/analysis , Asia , International Cooperation , Ozone/standards , Quality Control , Reference Standards , Spectrophotometry, Ultraviolet
4.
Infection ; 32(4): 246-8, 2004 Aug.
Article in English | MEDLINE | ID: mdl-15293083

ABSTRACT

We report a case of septic arthritis due to Ralstonia pickettii in an intravenous drug user with unfavorable clinical course under antibiotic therapy with ceftriaxone despite in vitro susceptibility to the drug. The treatment failure may have been due to a discrepancy between in vitro and in vivo susceptibility of R. pickettii, or to resistance development mediated by a recently described inducible beta-lactamase.


Subject(s)
Anti-Bacterial Agents/pharmacology , Anti-Bacterial Agents/therapeutic use , Arthritis, Infectious/drug therapy , Ceftriaxone/pharmacology , Ceftriaxone/therapeutic use , Gram-Negative Bacterial Infections/drug therapy , Ralstonia/pathogenicity , Substance Abuse, Intravenous , Adult , Arthritis, Infectious/pathology , Drug Resistance, Bacterial , Gram-Negative Bacterial Infections/pathology , Humans , In Vitro Techniques , Male , Microbial Sensitivity Tests , Reproducibility of Results
5.
J Environ Monit ; 6(3): 234-41, 2004 Mar.
Article in English | MEDLINE | ID: mdl-14999322

ABSTRACT

Near real-time measurements of light non-methane hydrocarbons (NMHCs) and peroxyacetyl nitrate (PAN) have been performed in the free troposphere using two fast gas chromatography (GC) instruments designed for use on aircraft. A GC-helium ionisation detector (HID) system measured 15 C(2)-C(5) hydrocarbons with 5 min time resolution and a dual channel GC-Electron Capture Detector (ECD) measured PAN with 90 s resolution. Both instruments had low parts per trillion by volume (pptV) detection limits and ran continuously at the remote Jungfraujoch (JFJ) research station in the Swiss Alps (46.55[degree]N, 7.98[degree]E), 3580 m above mean sea level (AMSL), during February/March 2003. Carbon monoxide, ozone, nitrogen oxide and nitrogen dioxide and all odd nitrogen species (NO(y)) were also measured continuously. Hydrocarbons and CO were strongly correlated in all air-masses whilst PAN exhibited both positive and negative correlations with respect to O(3), dependent on age and origin of the air-mass sampled. PAN was found to contribute [similar]20% to the NO(y) sampled on average. The experiment, as well as providing interesting datasets from this remote location, also demonstrated that when optimised, GC techniques have the potential to measure at a time resolution significantly greater than is traditionally considered, with high sensitivity and low uncertainty.


Subject(s)
Air Pollutants/analysis , Chromatography, Gas/instrumentation , Environmental Monitoring/instrumentation , Hydrocarbons/analysis , Peracetic Acid/analogs & derivatives , Peracetic Acid/analysis , Automation , Equipment Design , Sensitivity and Specificity
6.
Dtsch Med Wochenschr ; 128(19): 1048-50, 2003 May 09.
Article in German | MEDLINE | ID: mdl-12736855

ABSTRACT

HISTORY AND ADMISSION FINDINGS: A 54-year-old farmer with moderate mitral valve regurgitation was admitted to hospital because of suspected infective endocarditis. EXAMINATIONS: Echocardiography revealed a large mitral valve vegetation as the source of multifocal septic emboli to the central nervous system, spleen, mesenteric and femoro-popliteal arteries, eyes, and kidneys. Eventually an embolus removed from the femoro-popliteal artery and vegetations on the replaced mitral valve grew C. albicans. THERAPY: Despite treatment with amphotericin B and valve replacement the patient died of septicemia due to E. coli. CONCLUSION: Endocarditis due to C. albicans is commonly associated with severe complications. Diagnosis of this rare disease is often delayed because of negative blood cultures. Large cardiac vegetations and embolization of major arterial vessels should raise the suspicion of fungal endocarditis.


Subject(s)
Candida albicans/growth & development , Candidiasis/diagnosis , Endocarditis/microbiology , Sepsis/complications , Amphotericin B/therapeutic use , Candidiasis/complications , Candidiasis/drug therapy , Echocardiography , Embolism/etiology , Endocarditis/complications , Endocarditis/drug therapy , Escherichia coli Infections/complications , Fatal Outcome , Heart Valve Prosthesis , Humans , Male , Middle Aged , Mitral Valve/surgery , Mitral Valve Insufficiency/etiology , Mitral Valve Insufficiency/surgery
7.
Ther Umsch ; 59(1): 21-9, 2002 Jan.
Article in German | MEDLINE | ID: mdl-11851042

ABSTRACT

Antimicrobial resistance among respiratory tract pathogens has become an increasing problem worldwide during the last 10-20 years. The wide use of antimicrobial agents in ambulatory practice has contributed to the emergence and spread of antibiotic-resistant bacteria in the community, namely Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis. The pneumococcus has developed resistance to most antibiotics used for its treatment. Classes with important resistance problems include the beta-lactams, the macrolides, the lincosamides, trimethoprim-sulfamethoxazole, and the tetracyclines. Unfortunately, resistance to more than one class of antibiotics is common. In Haemophilus influenzae and Moraxella catarrhalis, resistance to beta-lactam antibiotics is the main concern currently. It is important to know the local resistance pattern of the most common respiratory tract pathogens in order to make reasonable recommendations for an empirical therapy for respiratory tract infection, when antibiotic therapy is indeed indicated.


Subject(s)
Anti-Bacterial Agents/administration & dosage , Bacterial Infections/drug therapy , Bronchitis/drug therapy , Drug Resistance, Bacterial/physiology , Respiratory Tract Infections/drug therapy , Anti-Bacterial Agents/adverse effects , Bacteria/drug effects , Bacterial Infections/microbiology , Bronchitis/microbiology , Humans , Microbial Sensitivity Tests , Respiratory Tract Infections/microbiology
SELECTION OF CITATIONS
SEARCH DETAIL
...